Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies. 2024

Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
Laboratory of Drug Discovery and Design, School of Pharmaceutical Sciences, Liaocheng University, Liaocheng 252000, China.

Human epidermal growth factor receptor 2 (HER2) is a key player in the pathogenesis and progression of breast cancer and is currently a primary target for breast cancer immunotherapy. Bioactivity determination is necessary to guarantee the safety and efficacy of therapeutic antibodies targeting HER2. Nevertheless, currently available bioassays for measuring the bioactivity of anti-HER2 mAbs are either not representative or have high variability. Here, we established a reliable reporter gene assay (RGA) based on T47D-SRE-Luc cell line that expresses endogenous HER2 and luciferase controlled by serum response element (SRE) to measure the bioactivity of anti-HER2 antibodies. Neuregulin-1 (NRG-1) can lead to the heterodimerization of HER2 on the cell membrane and induce the expression of downstream SRE-controlled luciferase, while pertuzumab can dose-dependently reverse the reaction, resulting in a good dose-response curve reflecting the activity of the antibody. After optimizing the relevant assay parameters, the established RGA was fully validated based on ICH-Q2 (R1), which demonstrated that the method had excellent specificity, accuracy, precision, linearity, and stability. In summary, this robust and innovative bioactivity determination assay can be applied in the development and screening, release control, biosimilar assessment and stability studies of anti-HER2 mAbs.

UI MeSH Term Description Entries
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074322 Antineoplastic Agents, Immunological Antineoplastic agents containing immunological agents (e.g. MAbs). These pharmacologic preparations inhibit or prevent the proliferation of NEOPLASMS. Antineoplastic MAbs,Antineoplastics, Monoclonal Antibodies,Antineoplastics, Monoclonal Antibody,MAbs, Antineoplastic,Monoclonal Antibodies, Antineoplastic,Antibodies Antineoplastics, Monoclonal,Antineoplastic Monoclonal Antibodies,Immunological Antineoplastic Agents,Monoclonal Antibodies Antineoplastics,Monoclonal Antibody Antineoplastics
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D061067 Antibodies, Monoclonal, Humanized Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab. Antibodies, Humanized,Humanized Antibodies
D017930 Genes, Reporter Genes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these genes may be attached to a promoter region of interest. Reporter Genes,Gene, Reporter,Reporter Gene

Related Publications

Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
October 2017, Journal of pharmaceutical and biomedical analysis,
Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
June 2016, Journal of pharmaceutical and biomedical analysis,
Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
December 2020, Luminescence : the journal of biological and chemical luminescence,
Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
August 2020, International immunopharmacology,
Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
January 2018, Journal of pharmaceutical and biomedical analysis,
Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
December 2019, RSC advances,
Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
October 2023, Analytical science advances,
Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
June 2021, Luminescence : the journal of biological and chemical luminescence,
Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
December 2021, International immunopharmacology,
Xiang Zhao, and Weizhu Qian, and Sheng Hou, and Yimei Wu, and Huaizu Guo, and Jin Xu, and Dapeng Zhang, and Jun Li, and Rongrong Fu, and Mengjiao Xu, and Fugui Wang
November 2018, Analytical and bioanalytical chemistry,
Copied contents to your clipboard!